The press release you referenced provides the following financial highlights for the second‑quarter 2025 period:
Metric | Q2 2025 | Q2 2024 |
---|---|---|
Total revenue | $142.2 million (up 16.4 %) | $122.2 million |
Net income | $7.8 million ($0.64 diluted) | $6.0 million ($0.50 diluted) |
Adjusted net income | $11.3 million ($0.93 adjusted diluted) | — |
Free cash flow (FCF) is not disclosed in the excerpt you provided. The summary lists revenue, net income, and adjusted net income, but it does not contain any figures for operating cash flow, capital expenditures, or free cash flow—nor does it give a comparison to prior periods for those cash‑flow metrics.
What you can do next
- Review the full earnings release – The complete press release (often available on the company’s investor‑relations website or via the Business Wire link) typically includes a cash‑flow statement and will state the quarter’s free cash flow and how it compares to the same quarter last year or to the previous quarter.
- Check the SEC Form 10‑Q – Limbac Holdings files quarterly reports with the SEC; the “Cash flows from operating activities” and “Capital expenditures” sections can be used to calculate free cash flow (FCF = Operating cash flow – CapEx).
- Listen to the earnings call transcript – Management often discusses cash‑flow performance and trends during the call, providing qualitative context (e.g., “free cash flow increased X% year‑over‑year”).
Bottom line: Based on the information you shared, the free cash flow amount for Q2 2025 and its trend relative to prior periods are not available. To obtain that data, you’ll need to consult the full earnings release, the company’s Form 10‑Q, or the accompanying earnings‑call discussion.
Other Questions About This News
Does management provide guidance for Q3 2025 and full-year 2025 performance?
How did gross margin and operating margin change compared to Q2 2024?
Is the increase in net income and adjusted EPS being driven by volume growth, pricing power, or cost reductions?
What were the primary drivers behind the 16.4% revenue increase year-over-year?
How does the EPS growth compare with analyst consensus and expectations?
What is the current debt level and any changes in leverage ratios?
What are the expected impacts of any macroeconomic or industry trends on future earnings?
What is the outlook for capital expenditures and potential impact on cash flow?
What is the current valuation multiple (e.g., P/E, EV/EBITDA) after this earnings release and how does it compare to peers?
How does the company's revenue growth compare to key competitors in the same market segment?
Are there any specific one-time items or non-recurring expenses affecting the reported net income?
Is there any change in management commentary on market positioning or product pipeline?
Did the company return any capital to shareholders via dividends or share repurchases during the quarter?
How does the adjusted net income figure compare to GAAP net income, and what adjustments were made?